Line 24: |
Line 24: |
| =Congestive Heart Failure= | | =Congestive Heart Failure= |
| * Systolic Dysfunction/HFrEF | | * Systolic Dysfunction/HFrEF |
| + | ** H&P: History of CAD, hypertension, valvular disease, dilated cardiomyopathy (EtOH, Chagas, Coxsackie B), or MI. Dyspnea, PND, orthopnea, cough, hemoptysis, fatigue; S3, displaced PMI, crackles, signs of right heart failure (S4, JVD, edema) |
| + | ** Dx: LVEF < 40%, enlarged cardiomediastinal silhouette on CXR, elevated BNP |
| + | ** Tx: ACEI/ARBs, ARNIs, β blockers, SGLT2 inhibitors, Spironolactone, and LVAD all have mortality benefit; Digoxin and diuretics don't have any mortality benefit but help with symptoms and decrease hospitalizations. For acute exacerbations use LMNOP (lasix, morphine, nitrates, oxygen, positioning). |
| * Non-systolic Dysfunction/HFpEF | | * Non-systolic Dysfunction/HFpEF |
| + | ** H&P: History of amyloidosis, sarcoidosis, hemochromatosis, or radiation leading to infiltrative or restrictive cardiomyopathy. |
| + | ** Dx: LVEF > 40% |
| + | ** Tx: SGLT2 inhibitors |
| | | |
| =Cardiomyopathy= | | =Cardiomyopathy= |